PROGRAM
Day 1
| Genetic Disorders to Consider in Echocardiography: Clinical Scenarios for Genetic Testing Chairperson: Sang Chol Lee (Sungkyunkwan Univ.), Eui-Young Choi (Yonsei Univ.) |
||
|---|---|---|
| 09:00-09:15 | Thickened Myocardium: HCM, Fabry, Mitochondrial Disorders, Amyloidosis, etc. | 88 |
| 09:15-09:30 | Ventricular Systolic Dysfunction: DCM, Duchenne/Becker, Mitochondrial Disorders, Danon, etc. | 125 |
| 09:30-09:45 | Aortopathy and Valvulopathy: Marfan, etc. | 78 |
| 09:45-10:00 | Pulmonary Hypertension | 133 |
| 10:00-10:20 | Panel Discussion | |
| Course Objective (KOR) | 286 | |
| Coffee Break | ||
|---|---|---|
| Young Investigator Award Chairperson: Joon-Han Shin (Ajou Univ.), Jang-Young Kim (Yonsei Wonju Univ.) |
||
|---|---|---|
| 10:50-11:06 | Prognostic Value of Right Ventricular Pulmonary Artery Coupling to a Clinical Risk Score in Tricuspid Regurgitation | 13 |
| 11:06-11:22 | The Effect of Mavacamten on Left Atrial Mechanics in Obstructive Hypertrophic Cardiomyopathy | 224 |
| 11:22-11:38 | Left Atrial Stain Late After Corrective Mitral Valve Surgery in Patients with Mitral Regurgitation: Impact of Surgical Techniques (Replacement vs. Repair) | 223 |
| 11:38-11:54 | Integrated Myocardial Work Index as a Predictor of Cardiovascular Outcomes in Mixed Aortic Valve Disease. | 222 |
| 11:54-12:10 | Echocardiographic Drag Effect Index Predicts Response to Mavacamten in Obstructive Hypertrophic Cardiomyopathy | 97 |
| Lunch & Scientific Session (2)_(유) 한국비엠에스제약 & 한국화이자제약 ㈜ Chairperson: Hyung-Kwan Kim (Seoul National Univ.) |
||
|---|---|---|
| 12:20-12:50 | Advancing Treatment Paradigms in Obstructive HCM | 109 |
| 12:50-13:20 | Value Added Solution for High-Risk Patients with Afib | 11 |
| Pulmonary Hypertension 2025: Imaging, Therapy, and Multidisciplinary Care Chairperson: Hae-Ok Jung (Catholic Univ. / Korea), Wook-Jin Chung (Gachon Univ. / Korea) |
English Session | |
|---|---|---|
| 13:20-13:35 | Echo in PH: Updated Standard Protocol for PH Diagnosis and Treatment Guiding | 133 |
| 13:35-14:05 | Recent Updates in Medical Treatment of PH: Are We Entering A Remission Era in PAH? | 215 |
| 14:05-14:20 | Multidisciplinary Team Approach in PH: What Makes A Real Difference in Outcomes | 7 |
| 14:20-14:40 | Panel Discussion | |
| Course Objective (ENG) | 287 | |
| Course Objective (KOR) | 288 | |
| Coffee Break | ||
|---|---|---|
| [JSE -Joint Session] Strain Imaging Across the Spectrum of Cardiovascular Disease Chairperson: Geu-Ru Hong (Yonsei Univ. / korea), Hiroyuki Okura (Gifu Univ. / Japan) |
English Session | |
|---|---|---|
| 15:10-15:25 | Aging and Strain: How Myocardial Function Changes Over Time | 184 |
| 15:25-15:40 | Strain Imaging in Valvular Heart Disease: From Assessment to Decision-Making | 25 |
| 15:40-15:55 | Strain Imaging in Cardio-Oncology: Detecting and Preventing Cardiotoxicity | 181 |
| 15:55-16:10 | Strain Imaging Across the Spectrum of Cardiovascular Disease | 185 |
| 16:10-16:30 | Panel Discussion | |
| Course Objective (ENG) | 292 | |
| Course Objective (KOR) | 291 | |
